Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03944850 · ClinicalTrials.gov registry record · NA
Computerized Anxiety Sensitivity Treatment for Opioid Use Disorders
A NA study of Opioid Use Disorder, sponsored by Southeast Louisiana Veterans Health Care System.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT03944850: Completed NA study of Opioid Use Disorder, sponsored by Southeast Louisiana Veterans Health Care System.
NCT03944850 is a NA study of Opioid Use Disorder that has completed, run by Southeast Louisiana Veterans Health Care System. The registered enrollment target is 32 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03944850, a NA study of Opioid Use Disorder, has completed, sponsored by Southeast Louisiana Veterans Health Care System.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of the current project is to test the acceptability and feasibility of a computerized intervention, titled Computerized Anxiety Sensitivity Treatment (CAST), delivered to Veterans seeking treatment for an opioid use disorder. The second aim of the study is to examine the utility of CAST by gathering data on symptom change. The final aim of the current study is to test the effects of CAST on rates of attendance and retention in a substance use disorder treatment (SUDT) program.
Primary Outcome
The IAQ is an 11-item self-report questionnaire designed to measure treatment satisfaction. The IAQ includes nine items assessing acceptability (e.g., Do you think the information provided during the computerized intervention was helpful? How likely are you to use the information and techniques you learned during the computerized intervention?), which are rated on a 4-point Likert-type scale (0 = no; 1 = somewhat; 2 = moderately; 3 = yes) and two free response items requesting suggestions for im
Conditions Studied
Interventions
- BEHAVIORAL Computerized Anxiety Sensitivity Treatment
Study Locations (1)
Louisiana
- Southeast Louisiana Veterans Health Care System - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2019-05-28 |
| Est. Completion | 2020-01-31 |
| Phase | NA |
What the finished NCT03944850 record still lists
NCT03944850 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Computerized Anxiety Sensitivity Treatment is the first listed.
NCT03944850 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT03944850 about?
NCT03944850 is a clinical study titled "Computerized Anxiety Sensitivity Treatment for Opioid Use Disorders". The primary aim of the current project is to test the acceptability and feasibility of a computerized intervention, titled Computerized Anxiety Sensitivity Treatment (CAST), delivered to Veterans seeking treatment for an opioid use disorder. The second aim of the study is to examine the utility of C...
What is the current status of trial NCT03944850?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2019-05-28. Estimated completion is 2020-01-31.
What conditions does trial NCT03944850 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT03944850?
The interventions under investigation include: Computerized Anxiety Sensitivity Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT03944850?
This trial is sponsored by Southeast Louisiana Veterans Health Care System, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03944850 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03944850's enrollment target sits among peer trials
32 202nd of 257 higher than 54 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI